Tag: Clinical trial outcomes

A recent clinical trial has brought ibogaine, a psychedelic substance renowned for its role in addiction therapy, into the spotlight as a potential breakthrough in treating post-traumatic stress disorder (PTSD). The study, conducted among military veterans with traumatic brain injuries, revealed a remarkable 80% reduction in PTSD and depression symptoms over a month-long period. While…